Telomir Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q4 2023 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Telomir Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2023 to Q2 2024.
  • Telomir Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -735 %.
Return On Equity, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -735 Apr 1, 2024 Jun 30, 2024
Q1 2024 -602 Jan 1, 2024 Mar 31, 2024
Q4 2023 -581 Oct 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.